Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Interleukin-17 aggravates right ventricular remodeling via activating STAT3 under both normoxia and hypoxia

Fig. 4

IL-17 inhibits cardiomyocyte viability via STAT3 under both normoxia and hypoxia condition. A Western blot analysis of IL-17 expression in cardiomyocytes after hypoxia exposure. **p < 0.01. B The protein expression of p-STAT3 in cardiomyocytes when treated with hypoxia exposure or/and IL-17. **p < 0.01, ***p < 0.001. C Cardiomyocyte viability measured by CCK-8 after treated with IL-17 or STAT3 inhibitor under normoxia and hypoxia. ***p < 0.001 (vs control group), ###p < 0.001 (vs IL-17 group)

Back to article page